Capricor Therapeutics Inc (CAPR)

R&D Expenses

$28.87M

Quarterly · Period ending: · USD

CAPR logo

CAPR R&D Expenses

Latest reported$28.87M
CAPR Quarterly R&D Expenses ($0.00 → $28.87M)
High-resolution chart · PNG

CAPR r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Capricor Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.